Update on Endothelin Receptor Antagonists in Hypertension

被引：0
|
作者：
Michel Burnier
机构：
[1] Centre Hospitalier Universitaire Vaudois,Department of Medicine, Service of Nephrology and Hypertension
来源：
Current Hypertension Reports | 2018年 / 20卷
关键词：
Antagonists; Experimental hypertension; Resistant hypertension; Renal; Proteinuria;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Endothelin receptor antagonists
    Xiang, JN
    Luengo, JI
    Ohlstein, EH
    Elliott, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1195 - U1195
  • [42] Endothelin receptor antagonists
    Edwards, P
    DRUG DISCOVERY TODAY, 2001, 6 (16) : 861 - 862
  • [43] The endothelin system and endothelin receptor antagonists
    Jandeleit-Dahm, Karin A. M.
    Watson, Anna M. D.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (01): : 66 - 71
  • [44] Endothelin receptor antagonists
    Cheng, TO
    CIRCULATION, 1997, 96 (10) : 3813 - 3813
  • [45] Endothelin receptor antagonists
    Joel B. Nelson
    World Journal of Urology, 2005, 23 : 19 - 27
  • [46] Endothelin antagonists and pulmonary hypertension
    Simonsen, U.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 18 - 18
  • [47] Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
    Meghan Aversa
    Sandra Porter
    John Granton
    Drug Safety, 2015, 38 : 419 - 435
  • [48] Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists
    Nejad, Sayeh Heidari
    Azzam, Omar
    Schlaich, Markus P.
    FUTURE CARDIOLOGY, 2024, 20 (09) : 435 - 445
  • [49] Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
    Aversa, Meghan
    Porter, Sandra
    Granton, John
    DRUG SAFETY, 2015, 38 (05) : 419 - 435
  • [50] Endothelin receptor antagonists for pulmonary arterial hypertension - Rationale and place in therapy
    Price, Laura C.
    Howard, Luke S. G. E.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (03) : 171 - 185
12345